China SXT Pharmaceuticals
SXTC
8 hedge funds and large institutions have $524K invested in China SXT Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
7% more capital invested
Capital invested by funds: $491K → $524K (+$33.5K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
20% less funds holding
Funds holding: 10 → 8 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$147K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$32.9K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$69.9K |
| 2 |
HF
HRT Financial
New York
|
-$42K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$24.3K |
| 4 |
VF
Virtu Financial
New York
|
-$24.1K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$6.29K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $241K | +$147K | +679 | +209% |
|
|
2
Invesco
Atlanta,
Georgia
| $137K | -$6.29K | -29 | -5% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $85.9K | – | – | – |
|
|
XT
4
XTX Topco
George Town,
Cayman Islands
| $36.4K | +$32.9K | +152 | New |
|
|
VF
5
Virtu Financial
New York
| $20K | -$24.1K | -111 | -58% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $2.92K | -$1.52K | -7 | -37% |
|
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$1.08K | +5 | New |
|
8
UBS Group
Zurich,
Switzerland
| $356 | – | – | – |
|
|
9
Renaissance Technologies
New York
| – | -$69.9K | -297 | Closed |
|
|
HF
10
HRT Financial
New York
| – | -$42K | -178 | Closed |
|
|
TSS
11
Two Sigma Securities
New York
| – | -$24.3K | -103 | Closed |
|
|
SOW
12
State of Wyoming
Cheyenne,
Wyoming
| – | -$142 | -1 | Closed |
|
SXTC Hedge Fund Activity: Q4 2025 in Review
8 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in China SXT Pharmaceuticals (SXTC) for Q4 2025, worth a combined $524K — up 6.8% from $491K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SXTC and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Citadel Advisors, adding an estimated $147K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $69.9K sold.
- 8 institutional investors held China SXT Pharmaceuticals (SXTC) as of Q4 2025, down from 10 in Q3 2025.
- Funds reported $524K of China SXT Pharmaceuticals stock for Q4 2025, up 6.8% quarter-over-quarter.
- 2 funds opened new China SXT Pharmaceuticals positions in Q4 2025 and 4 closed out, a net change of -2 holders.
- The largest China SXT Pharmaceuticals buyer in Q4 2025 was Citadel Advisors, an estimated $147K added.
- The largest China SXT Pharmaceuticals seller in Q4 2025 was Renaissance Technologies, an estimated $69.9K sold.
Based on aggregated 13F filings for Q4 2025.